Scott Giberson's most recent trade in SAB Biotherapeutics Inc was a trade of 150,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SAB Biotherapeutics Inc | Scott Giberson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2025 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| SAB Biotherapeutics Inc | Scott Giberson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| SAB Biotherapeutics Inc | Scott Giberson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2022 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) |